Literature DB >> 16322092

Roles for p21waf1/cip1 and p27kip1 during the adaptation response to massive intestinal resection.

Wolfgang Stehr1, Nicole P Bernal, Christopher R Erwin, Kathryn Q Bernabe, Jun Guo, Brad W Warner.   

Abstract

The magnitude of gut adaptation is a decisive factor in determining whether patients are able to live independent of parenteral nutrition after massive small bowel loss. We previously established that the cyclin-dependent kinase inhibitor (CDKI) p21(waf1/cip1) is necessary for enterocyte proliferation and a normal adaptation response. In the present study, we have further elucidated the role of this CDKI in the context of p27(kip1), another member of the Cip/Kip CDKI family. Small bowel resections (SBRs) or sham operations were performed in control (C57/BL6), p21(waf1/cip1)-null, p27(kip1)-null, and p21(waf1/cip1)/p27(kip1) double-null mice. Morphological (villus height/crypt depth) alterations in the mucosa, the kinetics of enterocyte turnover (rates of enterocyte proliferation and apoptosis), and the protein expression of various cell cycle-regulatory proteins were recorded at various postoperative times. Enterocyte compartment-specific mRNA expression was investigated using laser capture microdissection. Resection-induced adaptation in control mice coincided with increased protein expression of p21(waf1/cip1) and decreased p27(kip1) within 3 days postoperatively. Identical changes in mRNA expression were detected in crypt but not in villus enterocytes. Adaptation occurred normally in control and p27(kip1)-null mice; however, mice deficient in both p21(waf1/cip1) and p27(kip1) failed to increase baseline rates of enterocyte proliferation and adaptation. The expression of p21(waf1/cip1) protein and mRNA in the proliferative crypt compartment is necessary for resection-induced enterocyte proliferation and adaptation. The finding that deficient expression of p27(kip1) does not affect adaptation suggests that these similar CDKI family members display distinctive cellular functions during the complex process of intestinal adaptation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322092     DOI: 10.1152/ajpgi.00235.2005

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

Review 1.  Recent advances in small bowel diseases: Part II.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

2.  Regulation of retinoblastoma protein (Rb) by p21 is critical for adaptation to massive small bowel resection.

Authors:  Jennifer A Leinicke; Shannon Longshore; Derek Wakeman; Jun Guo; Brad W Warner
Journal:  J Gastrointest Surg       Date:  2011-11-01       Impact factor: 3.452

3.  EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats.

Authors:  L H Osaki; P M Figueiredo; E P Alvares; P Gama
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

4.  Functions of p21 and p27 in the regenerating epithelial linings of the mouse small and large intestine.

Authors:  Yu Zheng; Wenjun Bie; Ruyan Yang; Ansu O Perekatt; Aleksandra J Poole; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2008-03-07       Impact factor: 4.742

5.  Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis.

Authors:  Jessica A Clark; Andrew T Clark; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Shock       Date:  2008-07       Impact factor: 3.454

6.  Lessons learned: optimization of a murine small bowel resection model.

Authors:  Janice A Taylor; Colin A Martin; Rajalakshmi Nair; Jun Guo; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.